Aldosterone, Training, and Exercise: What Your Lab Values Mean for Performance and Health

Aldosterone is the main mineralocorticoid hormone made by the zona glomerulosa of the adrenal cortex. It is not a sex hormone and not the same as cortisol, though it is made in the same gland; its job is to manage sodium retention, potassium excretion, and blood volume through the renin-angiotensin-aldosterone system (RAAS). A single moderate-to-vigorous exercise session raises circulating aldosterone within minutes because sweat-related sodium loss and exercising-muscle potassium release both activate this system, and the elevation typically resolves within one to two hours of rest and rehydration. Consistent aerobic training, over weeks to months, is associated with lower resting aldosterone, most plausibly because expanded plasma volume reduces the physiologic stimulus for RAAS activity. A single resting aldosterone number, drawn without attention to posture, timing relative to exercise, and sodium intake, is frequently misleading and should not by itself be used to diagnose or exclude an adrenal problem.

The useful question for an active person is not "is my aldosterone high or low" but "was this value drawn under conditions that make it interpretable, and if it is genuinely elevated at rest, does it meet criteria that warrant a workup for primary aldosteronism." That distinction, not the raw number, is what determines next steps.

Why This Hormone Responds So Strongly to Exercise

The RAAS cascade starts when the kidney senses reduced perfusion or reduced sodium delivery to the distal nephron. Renin is released, angiotensin II is generated, and angiotensin II is the principal driver of aldosterone secretion. Elevated serum potassium independently stimulates the adrenal cortex to release aldosterone. Exercise produces both signals at once: sweating reduces plasma volume and sodium, and contracting muscle releases potassium into the circulation. This dual stimulus is why aldosterone is one of the more exercise-reactive hormones measured in routine endocrine panels. A general overview of RAAS physiology is available through the National Library of Medicine's StatPearls chapter on the renin-angiotensin system.

Why Timing and Posture Change the Number on Your Report

Preanalytical conditions materially affect aldosterone results. Standing upright for roughly 15 to 30 minutes before a blood draw increases aldosterone relative to a supine draw, because upright posture activates baroreceptor-mediated RAAS tone. Sodium intake in the days before the draw matters too: a high-sodium diet tends to suppress aldosterone, and a very low-sodium diet tends to raise it. Reference laboratories generally standardize collection to a fasting or non-fasting, seated, morning draw after a defined period upright, precisely because these variables move the result. General principles of standardized specimen collection are described by the CDC's laboratory standards program. If a sample was drawn shortly after a workout, in the afternoon, or during a period of sodium restriction, the number needs to be repeated under controlled conditions before it is used for any diagnostic conclusion.

What Counts as a Normal Range, and Where "Optimal" Gets Murkier

Aldosterone reference ranges vary somewhat by laboratory and assay, but a commonly cited adult range for a standardized seated morning draw is roughly 3 to 19 ng/dL (about 83 to 527 pmol/L). Values below the lower bound, especially with an elevated renin, can suggest adrenal insufficiency. Values above the upper bound should prompt calculation of an aldosterone-to-renin ratio (ARR) and consideration of secondary causes. The Endocrine Society's clinical practice guideline on primary aldosteronism is the accepted framework most U.S. clinicians use for these thresholds and for ARR-based screening; specific numeric cutoffs and testing protocols in that guideline should be confirmed directly against the current published version rather than assumed from a summary, since guideline updates and assay-specific cutoffs do change over time.

The idea that trained endurance athletes tend to run toward the lower-middle of the normal range at rest, reflecting expanded plasma volume and more efficient renal sodium handling, is physiologically plausible and consistent with the general RAAS-training literature. However, a precise "optimal" numeric band for athletes is not something this article can support with a verifiable primary source, and readers should not treat a specific number as a performance target. What is well established is the direction of the training effect (down), not a validated athlete-specific optimal range.

Decision Framework: Is This Aldosterone Result Trustworthy, and Does It Need Follow-Up?

Use this sequence before treating any aldosterone value as clinically meaningful.

The exception that matters most in practice: an athlete or highly active patient with a single elevated aldosterone and no elevated ARR, no hypokalemia, and no resistant hypertension almost never has primary aldosteronism. The next step is a repeat draw under controlled conditions, not an immediate confirmatory test.

How a Single Workout Changes Aldosterone

Sustained aerobic effort raises aldosterone within the first 10 to 20 minutes, and the rise tends to track with intensity and duration. Older exercise physiology research has reported that a session of roughly 60 minutes at moderate-to-vigorous intensity can double or triple aldosterone above resting baseline, with the elevation persisting for one to two hours afterward if fluid and sodium are not replaced. These are the kind of numbers commonly repeated in secondary sources, but a specific magnitude tied to a specific named study should be verified against the primary paper before being treated as an exact figure; this article states the direction and rough scale of the effect rather than an unverified precise multiplier from a single trial.

Lower-intensity activity (walking, easy cycling) produces a much smaller aldosterone change than sustained moderate-to-vigorous aerobic work. Resistance training also raises aldosterone acutely, though the published comparisons between resistance and aerobic exercise are less consistent, and any specific numeric comparison between modalities should be treated as provisional pending direct primary-source confirmation.

Does Regular Training Actually Lower Resting Aldosterone?

Chronic aerobic training is associated with plasma volume expansion, generally in the range of roughly 10 to 20% over the first several weeks of a new program, driven partly by red-cell mass changes and partly by the same aldosterone-mediated sodium and water retention that occurs early in training. As plasma volume stabilizes, resting RAAS activity, including resting aldosterone, tends to down-regulate. This is a plausible and commonly cited mechanism for part of the blood-pressure-lowering effect of regular aerobic exercise, and it is consistent with the broader body of evidence that structured aerobic activity reduces resting blood pressure, summarized in the American Heart Association's physical activity recommendations for adults (accessed 2025).

Resistance-only training programs have generally shown smaller or non-significant changes in resting aldosterone compared with aerobic programs in the literature this article could evaluate. For a patient whose specific goal is RAAS-related cardiovascular risk reduction, aerobic volume, not resistance training alone, is the better-supported lever, though combining both is reasonable and unlikely to be counterproductive.

Sodium, Potassium, and the Practical Hydration Question

Sweat sodium losses vary widely between individuals, and heavy sweating in heat can produce meaningful sodium deficits over an event or multiple daily sessions. Sodium deficit is itself a RAAS stimulus, so athletes training or competing repeatedly without adequate sodium replacement may run a chronically more activated RAAS between sessions. Potassium losses in sweat are smaller but still relevant on longer sessions, and extracellular potassium shifts from working muscle independently stimulate aldosterone release, apart from the sodium/volume pathway. General physiology of potassium's role in aldosterone regulation is reviewed in the NCBI StatPearls chapter on aldosterone. Practical sodium and fluid strategy for endurance events should follow current sports medicine guidance and, for anyone with a diagnosed cardiovascular or renal condition, a clinician's individualized advice rather than a generic template.

When an Elevated Result Is More Than a Training Artifact

Primary aldosteronism is widely recognized as the most common identifiable secondary cause of hypertension, and screening is generally recommended for patients with hypertension plus any of the following: spontaneous or diuretic-induced hypokalemia, resistance to three or more antihypertensive drugs, an adrenal incidentaloma, early-onset hypertension or stroke in a first-degree relative, or a first-degree relative with confirmed primary aldosteronism. These criteria come from the Endocrine Society's guideline framework; anyone matching one or more of them should have this discussed directly with their clinician rather than relying on a single lab value.

Persistently elevated aldosterone is not simply a blood-pressure issue. Observational data in patients with confirmed primary aldosteronism, compared with matched essential hypertension, have reported higher rates of cardiac structural changes such as left ventricular hypertrophy, independent of blood pressure level, consistent with a direct mineralocorticoid-receptor effect on cardiac tissue. Exact rates and statistical comparisons from any single study should be confirmed against the primary paper rather than cited as a fixed figure here. Regular aerobic exercise, through its RAAS-lowering effect, may plausibly reduce this risk pathway over time, but exercise is not a substitute for confirmed diagnosis and treatment of primary aldosteronism, which may include a mineralocorticoid receptor antagonist or, in unilateral disease, surgery.

Medications and Conditions That Distort the Test

Several common medications and situations change aldosterone or renin independently of true adrenal function, and should be reviewed before ordering or interpreting a panel:

• Diuretics and mineralocorticoid receptor antagonists (spironolactone, eplerenone) raise renin substantially and are generally recommended to be held for several weeks before confirmatory ARR testing, under a clinician's guidance.
• ACE inhibitors and ARBs raise renin and can produce false-negative ARR screens.
• Recent therapeutic phlebotomy (for example, in a TRT patient managing elevated hematocrit) acutely reduces plasma volume and can transiently raise aldosterone; testing soon after phlebotomy is not representative of steady state.
• Oral versus transdermal estrogen in menopausal hormone therapy: oral estrogen increases hepatic angiotensinogen production through first-pass metabolism, which can raise RAAS activity; transdermal estrogen largely avoids this effect. This is a plausible pharmacologic mechanism worth discussing with a prescriber if aldosterone or blood pressure is borderline, though individual response varies.
• GLP-1 receptor agonists are associated with weight loss and blood pressure reductions in clinical trials, which is broadly consistent with reduced RAAS activation from adipose tissue, but direct, prespecified aldosterone endpoints from GLP-1 trials are not something this article can confirm, and any specific aldosterone-reduction claim tied to these medications should be treated as unproven until directly verified in the primary literature.

A Practical Lab-Draw Checklist for People Who Train Regularly

Before an aldosterone or ARR panel, for anyone training more than a few times weekly:

• Avoid vigorous exercise for at least 48 hours before the draw; light walking is generally fine.
• Maintain a normal, consistent sodium intake in the days before the draw rather than an unusually low- or high-sodium period.
• Keep potassium intake consistent; do not add a large potassium supplement dose the night before.
• Draw in the morning, seated upright for the period specified by the lab (commonly 15-30 minutes), following the lab's own protocol.
• Draw aldosterone and renin (plasma renin activity or direct renin concentration) together so an ARR can be calculated.
• Review current medications with the ordering clinician beforehand, since several common drug classes distort the result.

A single abnormal result obtained outside these conditions is not diagnostic in either direction. The Endocrine Society framework requires confirmatory testing (such as oral sodium loading, saline infusion, fludrocortisone suppression, or captopril challenge, depending on clinical context) before a diagnosis of primary aldosteronism is made; a positive screening ARR alone is a reason to test further, not a diagnosis.

What Is Established, What Is Plausible, and What Is Not

Established: aldosterone rises acutely with moderate-to-vigorous exercise through combined sodium-loss and potassium-mediated stimulation of the RAAS; posture, sodium intake, and timing relative to exercise materially change lab results; primary aldosteronism is a recognized and likely underdiagnosed cause of secondary hypertension with defined screening criteria.

Plausible but not fully quantified in the material available here: the specific magnitude of aldosterone reduction from a given aerobic training program, an athlete-specific "optimal" aldosterone number, the precise size of the acute exercise-induced aldosterone spike from any single named trial, and the degree to which GLP-1 therapy or TRT specifically lowers aldosterone rather than affecting it indirectly through weight or hematocrit changes.

Not established from the evidence reviewed for this page: a validated aldosterone "performance target" for athletes, or a claim that exercise alone can substitute for confirmatory testing or treatment once primary aldosteronism is suspected.